3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Stomach Neoplasms
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroblastoma
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Interventions
Paclitaxel
42
Carboplatin
37
Bevacizumab
29
liposomal doxorubicin
20
Taxes
18
Specimen Handling
18
pembrolizumab
16
olaparib
16
Magnetic Resonance Spectroscopy
16
Gemcitabine
16
Topotecan
13
Immunoglobulin G
12
Disulfides
12
Biopsy
11
niraparib
8
mirvetuximab soravtansine
8
Nivolumab
7
Doxorubicin
7
Cyclophosphamide
6
Cisplatin
6
Drug Therapy
5
130-nm albumin-bound paclitaxel
5
cemiplimab
4
cediranib
4
Letrozole
4
Injections
4
Docetaxel
4
1-dodecylpyridoxal
4
sarilumab
3
rucaparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
IL32 protein, human
×
1 year
×
Clear all
No trials found.